Compare Gilead Sciences, Inc. (GILD) vs PAGSEG Inc (PAGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gilead Sciences, Inc. vs PAGSEG Inc — how do they compare? Gilead Sciences, Inc. trades at $132.99 (market cap $163.51B), while PAGSEG Inc trades at $9.21 (market cap $2.57B). The key difference: Gilead Sciences, Inc. is far larger — about 63.6× PAGSEG Inc's market cap, and PAGSEG Inc pays the higher dividend (11.29%). Which is the better fit depends on your goals.
| GILD | PAGS | |
|---|---|---|
Market Cap | $163.51B | $2.57B |
Sector | Health | Technology |
52-Week High | $155.80 | $12.00 |
52-Week Low | $108.22 | $7.75 |
Enterprise Value | $178.05B | $10.21B |
Dividend Yield | 2.49% | 11.29% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Gilead Sciences, Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →About PAGSEG Inc
PagSeguro Digital Ltd. is a leading provider of financial technology solutions in Brazil, primarily focused on e-commerce, face-to-face transactions, and financial services. The company's main offerings include PagBank, a digital banking platform, and PagSeguro, a suite of payment processing solutions that includes point-of-sale devices and online payment gateways. PAGS targets micro-merchants, small and medium-sized enterprises (SMEs), and consumers, aiming to democratize access to financial services in the country.
Read more on PAGS →
